This inventor holds 2 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Beijing Jitai Life Sciences Ltd., Beijing Jitai Pharmaceutical Technology Co., Ltd., Hangzhou Jitai Life Sciences Ltd. Active years: 2024-2026.
Company Filing History:
1 out of 2 
1 out of 1 
1 out of 1 Years Active: 2024-2026
Title: The Innovative Contributions of Caida Lai
Introduction
Caida Lai is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceutical technology, particularly through his innovative work on ionizable lipid compounds. His research focuses on enhancing the delivery of nucleic acids, which has important implications for medical treatments.
Latest Patents
Caida Lai holds a patent for ionizable lipid compounds. This patent describes a class of ionizable lipid compounds represented by a specific formula, along with their pharmaceutically acceptable salts, isotopic variants, tautomers, or stereoisomers. Additionally, the patent includes a nanoparticle pharmaceutical composition that comprises these compounds, highlighting their application in the delivery of nucleic acids.
Career Highlights
Throughout his career, Caida Lai has worked with several prominent companies in the pharmaceutical sector. Notably, he has been associated with Beijing Jitai Pharmaceutical Technology Co., Ltd. and Hangzhou Jitai Pharmaceutical Technology Co., Ltd. His work in these organizations has contributed to advancements in drug delivery systems and pharmaceutical formulations.
Collaborations
Caida Lai has collaborated with several professionals in his field, including Lin Zhang and Liu Yang. These collaborations have fostered a productive environment for innovation and research, leading to the development of new technologies in pharmaceutical science.
Conclusion
Caida Lai's contributions to the field of pharmaceutical technology, particularly through his patent on ionizable lipid compounds, demonstrate his commitment to advancing medical science. His work continues to influence the development of effective drug delivery systems.